BruceEReidenbergMD

Medical Director, HVDDSO NYS Office for People with Developmental Disabilities

Dr. Reidenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1985 - 1989
Weill Cornell MedicineClass of 1985

PubMed

9 citations
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients.
Bruce E. Reidenberg, Christoph Wanner, Bruce Polsky, Mariana Castanheira, Alla Shelip
European Journal of Clinical Microbiology & Infectious Diseases. 2018-04-01
9 citations
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate
Jörg Hamacher, Jörg Luepke, Bruce E. Reidenberg, Carl Erik Nord, Klaus Borner
Clinical Microbiology and Infection. 1999-06-01
1 citations
COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes.
K M Hirsch, B E Reidenberg
Public Health. 2022-08-01

Journal Articles

COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes
K M Hirsch and B E Reidenberg, Public Health / Elsevier

CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to Be Published in the European Journal of Clinical Microbiology and Infectious DiseasesDecember 5th, 2017